Summary
Boston Scientific Corporation (BSX) filed an 8-K on October 21, 2003, primarily to report on its financial results for the third quarter ended September 30, 2003. The report includes a press release dated October 21, 2003, which contains the company's financial performance for the quarter. Investors should note that the information provided in this filing is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities or automatic incorporation into other filings. The key takeaway for investors is the announcement of Q3 2003 financial results. While the specific figures are detailed in the referenced press release (Exhibit 99.1), this 8-K serves as the official notification of that release. Investors interested in BSX's performance during this period should refer to the press release for comprehensive details on revenue, profitability, and any forward-looking statements or strategic updates provided by management.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its financial results for the third quarter ended September 30, 2003.
- 2The company filed a Form 8-K on October 21, 2003, to report these results.
- 3The financial results were detailed in a press release issued by the company on October 21, 2003 (Exhibit 99.1).
- 4This filing serves as a notification mechanism for the Q3 financial performance update.
- 5Information furnished in this report is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.